04:54 PM EST, 02/28/2025 (MT Newswires) -- Ourania Tatsis, Executive Vice President, Chief Regulatory and Quality Officer, on February 26, 2025, sold 530 shares in Vertex Pharmaceuticals ( VRTX ) for $251,930. Following the Form 4 filing with the SEC, Tatsis has control over a total of 58,539 common shares of the company, with 58,539 shares held directly.
SEC Filing:
https://www.sec.gov/Archives/edgar/data/875320/000087532025000135/xslF345X05/wk-form4_1740779311.xml